Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 14Unknown 4Recruiting 3Not yet recruiting 2Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13Brain Neoplasms 9Prostatic Neoplasms 7Neoplasms 7Head and Neck Neoplasms 6Motor Activity 4Glioma 4Glioblastoma 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Colorectal Neoplasms 3Quality of Life 2Papillomavirus Infections 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Melanoma 2Lymphoma, Follicular 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Cancer Pain 2Biliary Tract Neoplasms 2Behavior 2Weight Loss 1Venous Thromboembolism 1Ureteral Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Prostatic Hyperplasia × Clear all
NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Northwell Health

Phase NA Suspended
20 enrolled
Genitourinary

Prostatic Hyperplasia, Nocturia, Dysuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡